AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyciday M 30mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Beats Pharmaceuticals

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Glyciday M 30mg/500mg Tablet

Diabetic patients using Metformin/Glimepiride 30mg/500mg tablets (a dual-action antidiabetic medication) should adhere to prescribed dosage and timing. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Consistent daily intake, preferably with meals, maximizes effectiveness. Dosage adjustments, based on individual blood sugar monitoring, are determined by your physician. Discontinuing treatment without medical supervision is risky; uncontrolled blood sugar elevates the chances of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan involving diet, physical activity, and weight management as recommended by your healthcare professional. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. Always carry a readily available glucose source (e.g., sugary snacks or juice) to counteract hypoglycemia. Constipation, nausea, and vomiting are also possible. Alcohol consumption should be minimized due to its potential for exacerbating hypoglycemia. Additional side effects may encompass altered taste perception, diarrhea, abdominal discomfort, and upper respiratory infections. Weight gain is another potential consequence. This medication is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiac issues should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are crucial for safe and effective treatment.

Uses of Glyciday M 30mg/500mg Tablet

Non-insulin-dependent diabetes

Major Benefits of Glyciday M 30mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glyciday M 30mg/500mg Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer this medication with a meal.

Common Side effects of Glyciday M 30mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glyciday M 30mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Glyciday M 30mg/500mg Tablets. Ingest each tablet whole; avoid crushing, chewing, or breaking it. Consume with a meal.

How Glyciday M 30mg/500mg Tablet works:

Gliclazide and metformin, combined in Glyciday M 30mg/500mg tablets, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glyciday M 30mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Taking Glyciday M 30mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Use is contraindicated except in rare, life-threatening circumstances where the potential benefits outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glyciday M 30mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glyciday M 30mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is necessary. Glyciday M 30mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyciday M 30mg/500mg tablets cautiously, potentially requiring dosage modification. Medical consultation is advised. Low initial doses are typically prescribed for those with mild to moderate hepatic dysfunction; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glyciday M 30mg/500mg Tablet :

Should you forget a Glyciday M 30mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyciday M 30mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glyciday M 30mg/500mg Tablet

Glyciday M 30mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used concurrently with a healthy diet and exercise regimen. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This combination therapy is unsuitable for type 1 diabetes.
Glyciday M 30mg/500mg tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects, including lactic acidosis, can also occur. Prolonged use may result in vitamin B12 deficiency.
Indeed, Glyciday M 30mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar include nausea, headache, irritability, hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry readily available glucose sources such as glucose tablets, honey, or fruit juice.
Glyciday M 30mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon side effect of metformin. Its occurrence is minimized by avoiding use in individuals with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Lactic acidosis symptoms might present as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Seek immediate medical attention and discontinue Glyciday M 30mg/500mg Tablet use if these symptoms appear.
Glyciday M 30mg/500mg tablets may induce vitamin B12 deficiency with prolonged administration. This deficiency arises from the medication's interference with gastric vitamin B12 absorption. Untreated, this can lead to anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Prophylactic yearly supplementation with exogenous vitamin B12 has been proposed by some investigators to mitigate these risks.
Patients with hypersensitivity to any ingredient or inactive component within Glyciday M 30mg/500mg Tablet should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Glyciday M 30mg/500mg Tablet and alcohol is unsafe. Alcohol consumption may exacerbate hypoglycemia and raise the risk of lactic acidosis.
Glyciday M 30mg/500mg tablets contain gliclazide and metformin, acting together to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when combined with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and boosts insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Glyciday M 30mg/500mg tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Less frequent, but potentially serious, side effects include lactic acidosis. Prolonged treatment might result in vitamin B12 deficiency.
Indeed, Glyciday M 30mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. This adverse effect is more probable if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or concomitant antidiabetic medication is administered. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Glyciday M 30mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent adverse reaction to metformin. To prevent it, avoid use in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Lactic acidosis symptoms can include muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms appear, discontinue Glyciday M 30mg/500mg tablets and seek immediate medical attention.
Prolonged Glyciday M 30mg/500mg Tablet consumption can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated, this deficiency may manifest as anemia, neurological issues, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at least annually, has been proposed by some studies.
Patients with a known hypersensitivity to any ingredient or inactive component within Glyciday M 30mg/500mg Tablets should not use this medication. Similarly, its use is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glyciday M 30mg/500mg tablets is unsafe. This combination may exacerbate hypoglycemia and raise the risk of lactic acidosis.
Glyciday M 30mg/500mg Tab...
41
MRP 50
18% off